$BWXT

BWX Technologies earnings beat by $0.08, revenue fell short of estimates

BWX Technologies (NYSE: BWXT) reported Q3 EPS of $1.26, beating estimates by $0.08, but revenue of $953M missed expectations of $970.42M. The company guided FY 2026 EPS to $4.72-$4.77 and revenue to $3.80B, both slightly below consensus. The stock is down 21.73% over the last 3 months and 39.57% over the last year.

Original reporting
Published Nov 2, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BWXT
Neutral
high confidence
Mentioned
$BWXT
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BWXTNeutralMed
01

Why it matters

The earnings beat provides a short‑term catalyst, but revenue miss and flat guidance may limit longer‑term upside.

02

Market read

Primary earnings disclosure for a mid‑cap defense contractor; relevant for sector traders and short‑term equity investors.

03

What to watch

Guidance remains near consensus, indicating management expects stable performance; the beat may be a one‑off.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

BWX Technologies (NYSE: BWXT) is a U.S. nuclear components and services provider. The article summarizes its Q3 earnings release and FY 2026 outlook.

Company-level read

Ticker impact

$BWXTNeutralHigh confidence
Context

BWX Technologies reported Q3 EPS of $1.26, beating estimates by $0.08 and provided FY 2026 guidance.

Expected impact

potential modest upside as market prices in the earnings beat, tempered by revenue shortfall

Evidence & confidence

Earnings surprise is a fresh primary disclosure; investors typically react to beat‑and‑miss patterns.

Market effects

Defense and nuclear services sector may see modest re‑rating based on BWX's results.

U.S. defense stocks could experience slight ripple effects.

Limited to investors tracking U.S. defense contractors.

Counterpoint

Revenue miss suggests underlying demand weakness; a short position could be justified despite EPS beat.

Key entities

  • BWX Technologies

    U.S. nuclear services and components manufacturer.

Related articles

$BWXTMedAI 8/10

BWXT Q3 2026 Earnings Call Transcript

BWXT reported Q3 2026 revenue of $953M, up 10% YoY, with Adjusted EBITDA at $180M and EPS at $1.26. Government Operations saw 22.6% EBITDA margin, while Commercial Operations grew 25%. The company secured contracts for nuclear projects, including the U.S. Army's Janus Program and a Canadian microreactor project. BWXT raised its 2026 free cash flow guidance to $350M-$360M and plans capacity expansions.

$BWXTMedAI 8/10

BWX Technologies Q3 Earnings Call Highlights

BWX Technologies reported Q3 highlights, including a $189M fuel contract and revenue growth in special materials. The company is advancing nuclear projects, such as a high-enriched uranium facility and a large-scale HPDU plant. BWXT also secured awards for its advanced nuclear reactors and raised its 2026 free-cash-flow outlook to $350M-$360M, maintaining adjusted EBITDA and EPS guidance.

$BWXTMed

BWX (NYSE:BWXT) misses Q3 2026 sales expectations

BWX reported Q3 2026 revenue of $953M, missing estimates by 2.1% but beating EPS expectations. Adjusted EBITDA and free cash flow margins improved. Management maintained full-year EPS guidance at $4.74 and raised EBITDA guidance. Backlog grew 15.6% year-on-year to $8.56B.